DIA
IONS icon

Dana Investment Advisors’s Ionis Pharmaceuticals IONS Stock Holding History

Dana Investment Advisors’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.85M Buy
23,272
+4,785
+26% +$360K 0.05% 350
2026
Q1 		$1.39M Buy
18,487
+461
+3% +$36.4K 0.04% 367
2025
Q4 		$1.43M Sell
18,026
-792
-4% -$59.6K 0.04% 358
2025
Q3 		$1.23M Buy
+18,818
New +$919K 0.04% 364

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Dana Investment Advisors's IONS Position: Q2 2026 in Review

Dana Investment Advisors increased its Ionis Pharmaceuticals (IONS) stake by 26% in Q2 2026, buying an estimated $360K and bringing the position to 23,272 shares worth $1.85M. The position accounts for 0.05% of the portfolio, ranked #350.

Dana Investment Advisors first reported a position in IONS in Q3 2025 and has held it in 4 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • Dana Investment Advisors held 23,272 shares of Ionis Pharmaceuticals worth $1.85M as of Q2 2026.
  • Dana Investment Advisors bought 4,785 Ionis Pharmaceuticals shares in Q2 2026, an estimated $360K.
  • Ionis Pharmaceuticals made up 0.05% of Dana Investment Advisors's portfolio in Q2 2026, its #350 holding.
  • Dana Investment Advisors first reported a position in Ionis Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on Dana Investment Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.